Delivery Order SPE2DB22D1106-SPE2DB24FERB4
- Not listed
- This federal contract award, valued at $18,150.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with a performance period ending on March 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $77,021.70 firm-fixed-price delivery order is for 4564450110 - BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,594.39 firm-fixed-price contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of BIKTARVY 50-200-25 MG TABLET. The $31,105.93 firm fixed-price delivery order has a completion date of September 6, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,603.48 firm fixed-price delivery order is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, valued at $77,205.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the medical product BIKTARVY 50-200-25 MG TABLET UU 30S. The award has an ultimate completion date of February 15, 2024, and a pricing type of Firm Fixed Price. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,159.67 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of September 21, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $68,493.14 delivery order contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of September 28, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a fixed price of $20,689.08 and a period of performance through January 16, 2024. It is a delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s, with a ceiling value of $49,634.87 and a completion date of December 6, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FERB4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,801.18 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a performance period through May 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a comprehensive range of pharmaceutical and medical supply products. This contract award does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 5/9/24 |